高级检索
当前位置: 首页 > 详情页

Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinoma

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Hepatology, ShuGuang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. [2]The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, China. [3]Xiamen University, Xiamen, Fujian Province, China. [4]Changhai Hospital, The Second Military Medical University, Shanghai, China. [5]Hepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian Province, China. [6]College of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China.
出处:

关键词: Glycosylation Nonalcoholic fatty liver disease Hepatocellular carcinoma Immunotherapy Machine learning

摘要:
The incidence of non-alcoholic fatty liver disease (NAFLD) associated hepatocellular carcinoma (HCC) has been increasing. However, the role of glycosylation, an important modification that alters cellular differentiation and immune regulation, in the progression of NAFLD to HCC is rare.We used the NAFLD-HCC single-cell dataset to identify variation in the expression of glycosylation patterns between different cells and used the HCC bulk dataset to establish a link between these variations and the prognosis of HCC patients. Then, machine learning algorithms were used to identify those glycosylation-related signatures with prognostic significance and to construct a model for predicting the prognosis of HCC patients. Moreover, it was validated in high-fat diet-induced mice and clinical cohorts.The NAFLD-HCC Glycogene Risk Model (NHGRM) signature included the following genes: SPP1, SOCS2, SAPCD2, S100A9, RAMP3, and CSAD. The higher NHGRM scores were associated with a poorer prognosis, stronger immune-related features, immune cell infiltration and immunity scores. Animal experiments, external and clinical cohorts confirmed the expression of these genes.The genetic signature we identified may serve as a potential indicator of survival in patients with NAFLD-HCC and provide new perspectives for elucidating the role of glycosylation-related signatures in this pathologic process.©2024 Zhou et al.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 生物学
小类 | 3 区 综合性期刊
最新[2025]版:
大类 | 3 区 生物学
小类 | 3 区 综合性期刊
第一作者:
第一作者机构: [1]Department of Hepatology, ShuGuang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
共同第一作者:
通讯作者:
通讯机构: [5]Hepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian Province, China. [6]College of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号